CMO Cell Free DNA Informatics
  • CMO Cell-Free DNA Informatics (CCI) Wiki
  • The Team
    • Mission and Values
    • Meet the Team!
    • Flagship Projects
    • Applications
  • The OnBoarding
    • General
    • Computational Biologist
      • MSK-ACCESS V1
        • Workflows V1
      • CMO-CH V1
      • Analysis
    • Software Engineers
    • Collaborations
    • Glossary
  • The Formal Stuff
    • Requesting Time Off
    • Filing Expenses
Powered by GitBook
On this page
  • What is CMO-CH assay?
  • What is the panel design?

Was this helpful?

Export as PDF
  1. The OnBoarding
  2. Computational Biologist

CMO-CH V1

This wiki explains the CMO-CH V1 assay

PreviousWorkflows V1NextAnalysis

Last updated 3 years ago

Was this helpful?

What is CMO-CH assay?

CMO-CH is offered by the Center for Molecular Oncology (CMO) to MSK researchers for profiling white blood cell DNA to detect mutations in the most commonly altered (CH) associated genes.

What is the panel design?

  • 596 targets capturing 58% of CH and 90.4% of CH-PD mutations identified in the latest CH dataset from 40K patients

  • Total size = 1,143 probes (0.14 Mb)

  • Full gene coverage for TP53, TET2, ASXL1, DNMT3A, PPM1D, CHEK2, ASXL1, ATM, SF3B1, SRSF2, U2AF1, and U2AF2•Additional targets with hotspot positions from IMPACT heme assay

  • SNP tiling around TP53, CBL, MPL, JAK2, EZH2, TET2, RUNX1, and ATM (+/-10kb) to identify allelic-imbalances

  • 40 fingerprint SNPs that are shared with all other NGS assays (IMPACT, ACCESS, WES etc.) to detect sample mismatches

clonal hematopoiesis